Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Neuland Laboratories Business Update

Neuland Laboratories announced the completion of a US FDA inspection at its Unit 3 facility. The regulator issued a Form 483 with one procedural observation.

Source

BSE filing, NSE: NEULANDLAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Neuland Laboratories Ltd: key numbers

Share price
₹19,250.00
Market cap
₹24,698 Cr
Revenue (annual)
₹2,023 Cr
Net profit (annual)
₹364.0 Cr
P/E (TTM)
49.6×Sector 46.1×
Promoter holding
32.26%-0.36% QoQ
FII holding
21.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Neuland Laboratories Ltd

All →

Other business update announcements

All →